REBECCA MORAN: Open Payments
NPI 1750045373 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 27 payments from 16 companies in 2025. Trend: 2023 $613 · 2024 $1,163 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Daiichi Sankyo Inc. | 3 | $88 |
| BeOne Medicines USA, Inc. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Incyte Corporation | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| TerSera Therapeutics LLC | 1 | $32 |
| Kite Pharma, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: ENHERTU, BRUKINSA, KISQALI, Nubeqa, MONJUVI, NINLARO, Zoladex, TAGRISSO.
Industry payments across GA — which companies pay providers there.
